{'fraction_non_alphanumeric': 0.021621621621621623, 'fraction_numerical': 0.0018018018018018018, 'mean_word_length': 5.95, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Angiotensin-converting enzyme inhibition: beyond blood pressure control – the role of zofenopril

The article highlights the main provisions of the review, which investigated the scope of clinical use of ACE inhibitors, in particular zofenopril, outside the control of blood pressure. Generalized clinical data are presented, indicating the benefits of its use in various diseases, in particular for the treatment of arterial hypertension, progression of chronic kidney disease, myocardial infarction, congestive heart failure and type 2 diabetes mellitus